Phathom Pharmaceuticals (PHAT) Treasury Shares (2019 - 2026)

Phathom Pharmaceuticals (PHAT) has reported Treasury Shares for 8 consecutive years, with $3.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Treasury Shares rose 17.25% year-over-year to $3.1 million; the TTM figure through Jun 2026 stood at $3.1 million (up 17.25% YoY), while the FY2025 annual figure was $2.2 million, down 9.57% from the prior year.
• Treasury Shares advanced to $3.1 million in Q2 2026 per PHAT's latest filing, from $3.0 million in the prior quarter.
• Across five years, Treasury Shares topped out at $3.3 million in Q1 2025 and bottomed at $19.0 in Q2 2023.
• Historically, Treasury Shares has averaged $1.5 million across 5 years, with a median of $1.5 million in 2022.
• Annual changes were most pronounced in 2023 — Treasury Shares tumbled 100.0% — and 2024, when it jumped 15313463.16%.
• Phathom Pharmaceuticals' Treasury Shares stood at $254437.0 in 2022, then tumbled by 99.99% to $19.0 in 2023, then changed by 0.0% to $19.0 in 2024, then soared by 11339815.79% to $2.2 million in 2025, then jumped by 43.31% to $3.1 million in 2026.
• Business Quant data shows PHAT's Treasury Shares at $3.1 million in Q2 2026, $3.0 million in Q1 2026, and $2.2 million in Q4 2025.